Cystatin C and Estimated Glomerular Filtration Rate as Predictors for Adverse Outcome in Patients with ST-Elevation and Non–ST-Elevation Acute Coronary Syndromes: Results from the Platelet Inhibition and Patient Outcomes Study
Author(s) -
Axel Åkerblom,
Lars Wallentin,
Agneta Siegbahn,
Richard C. Becker,
Andrzej Budaj,
Kristen Buck,
Evangelos Giannitsis,
Jay Horrow,
Steen Husted,
Hugo A. Katus,
Philippe Gabríel Steg,
Robert F. Storey,
Nils Åsenblad,
Stefan James
Publication year - 2011
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2011.171520
Subject(s) - cystatin c , renal function , medicine , hazard ratio , acute coronary syndrome , creatinine , myocardial infarction , cardiology , kidney disease , cystatin , st elevation , proportional hazards model , quartile , population , confidence interval , environmental health
We evaluated the predictive ability of cystatin C and creatinine-based estimations of glomerular filtration rate (eGFR), including the Chronic Kidney Disease-Epidemiology (CKD-EPI) equation, in acute coronary syndrome (ACS) patients with (STE-ACS) or without (NSTE-ACS) ST elevation in a large contemporary ACS population.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom